Skip to main content

Table 1 Antifungal interactions (FICI) between complex II and III inhibitors tested against filamentous fungi in microtiter plates1.

From: Antifungal activity of redox-active benzaldehydes that target cellular antioxidation

Combinations A

MIC alone

MIC combined

FICI

MIC alone

MIC combined

FICI

MIC alone

MIC combined

FICI

Strains

A. terreus UAB698

  

A. terreus UAB680

  

A. terreus UAB673

  

Kre-Me

Carboxin

> 1.62

> 1283

0.2 - 0.4

8 - 16

0.19 S

> 1.6

> 128

0.2 - 0.4

4 - 8

0.16 S

> 1.6

> 128

0.2 - 0.4

8 - 16

0.19 S

Pyraclostrobin

Carboxin

> 1.6

> 128

0.0 - 0.05

4 - 8

0.05 S

> 1.6

> 128

0.0 - 0.05

4 - 8

0.05 S

> 1.6

> 128

0.0 - 0.05

4 - 8

0.05 S

AntimycinA

Carboxin

> 1.6

> 128

0.4 - 0.8

8 - 16

0.31 S

> 1.6

> 128

0.4 - 0.8

16 - 32

0.38 S

> 1.6

> 128

0.4 - 0.8

16 - 32

0.38 S

Strains

A. flavus NRRL3357

  

A. fumigatus AF293

  

P. expansum NRRL974

  

Kre-Me

Carboxin

0.4 - 0.8

> 128

0.0 - 0.05

0.5 - 1

0.07 S

> 1.6

> 128

0.0 - 0.05

2 - 4

0.03 S

0.4 - 0.8

32 - 64

0.0 - 0.05

0.5 - 1

0.08 S

Pyraclostrobin

Carboxin

0.4 - 0.8

> 128

0.0 - 0.05

0.125 - 0.25

0.06 S

0.8 - 1.6

32 - 64

0.0 - 0.05

1 - 2

0.06 S

0.4 - 0.8

2 - 4

0.0 - 0.05

0.25 - 0.5

0.19 S

AntimycinA

Carboxin

0.4 - 0.8

> 128

0.2 - 0.4

4 - 8

0.53 A

0.8 - 1.6

> 128

0.2 - 0.4

4 - 8

0.28 S

0.4 - 0.8

> 128

0.05 - 0.1

2 - 4

0.14 S

Combinations B

MIC alone

MIC Combined

FICI

MIC alone

MIC combined

FICI

MIC alone

MIC combined

FICI

Strains

A. terreus UAB698

  

A. terreus UAB680

  

A. terreus UAB673

  

Kre-Me

TTFA

> 1.62

> 1283

0.2 - 0.4

4 - 8

0.16 S

> 1.6

> 128

0.2 - 0.4

16 - 32

0.25 S

> 1.6

> 128

0.2 - 0.4

16 - 32

0.25 S

Pyraclostrobin

TTFA

> 1.6

> 128

0.1 - 0.2

4 - 8

0.09 S

> 1.6

> 128

0.2 - 0.4

4 - 8

0.16 S

> 1.6

> 128

0.2 - 0.4

4 - 8

0.16 S

AntimycinA

TTFA

> 1.6

> 128

0.4 - 0.8

32 - 64

0.50 S

> 1.6

> 128

0.4 - 0.8

32 - 64

0.50 S

> 1.6

> 128

0.8 - 1.6

32 - 64

0.75 A

Strains

Compounds

A. flavus NRRL3357

  

A. fumigatus AF293

  

P. expansum NRRL974

  

Kre-Me

TTFA

> 1.6

> 128

0.4 - 0.8

16 - 32

0.38 S

> 1.6

> 128

0.2 - 0.4

8 - 16

0.19 S

> 1.6

16 - 32

0.4 - 0.8

4 - 8

0.50 S

Pyraclostrobin

TTFA

> 1.6

> 128

0.4 - 0.8

8 - 16

0.31 S

> 1.6

> 128

0.1 - 0.2

4 - 8

0.09 S

> 1.6

4 - 8

0.05 - 0.1

1 - 2

0.28 S

AntimycinA

TTFA

> 1.6

> 128

> 1.6

> 128

1.00 N

> 1.6

> 128

0.8 - 1.6

32 - 64

0.75 A

> 1.6

> 128

0.00 - 0.05

8 - 16

0.08 S

  1. 1 Compound interactions were determined as Fractional Inhibitory Concentration Indices (FICI), described by Isenberg ([47]; See also Methods). For calculation purposes, the higher concentration in each column was used. A, additive; N, neutral; S, synergistic. Complex II inhibitors (μg/ml)- Carboxin, Thenoyltrifluoroacetone (TTFA); Complex III inhibitors (mM)- Kresoxim methyl (Kre-Me), Pyraclostrobin, Antimycin A. Drug combinations for calculating FIC indices were: (Combinations A) Kre-Me + carboxin, pyraclostrobin + carboxin, and antimycin A + carboxin, and (Combinations B) Kre-Me + TTFA, pyraclostrobin + TTFA, and antimycin A + TTFA.
  2. 2 Since antifungal test was performed up to 1.6 mM of strobilurins or antimycin A (See Methods), 3.2 mM (doubling of 1.6 mM) was used for calculation purposes.
  3. 3 Since antifungal test was performed up to 128 μg/ml of carboxin or TTFA (See Methods), 256 μg/ml (doubling of 128 μg/ml) was used for calculation purposes.